A few months ago we reported on a drug company called ZMapp that was testing, and having some luck, treating Ebola patients with a drug sourced from a tobacco plant. Now ZMapp, working alongside Vanderbilt University, have received a donation of blood from an Ebola survivor, hoping to extract and map Ebola survivor’s proteins leading eventually to a cure.
Cure for Ebola could lie in survivor’s blood
More of Today's Solutions
Vision board ideas for adults: how to create one that inspires real change
BY THE OPTIMIST DAILY EDITORIAL TEAM A vision board might look like a crafty throwback to childhood afternoons spent collaging. But don’t write it ...
Read MoreIndia’s social experiment: how paying women directly reshapes welfare, autono...
BY THE OPTIMIST DAILY EDITORIAL TEAM Across India, millions of women now receive a modest but unwavering deposit each month into their bank accounts. ...
Read MoreNew Zealand’s groundbreaking shift to renewables promises massive emiss...
New Zealand launched its most ambitious emissions reduction initiative to date in an incredible undertaking. The government announced a historic switch from coal to ...
Read MoreGoing for the goal: the impact of team sports on boosting young girls’ ...
In a pioneering study, the Here for Every Goal report demonstrates that team sports, particularly elite women's soccer (referenced from here on in this ...
Read More
